Contact
Please use this form to send email to PR contact of this press release:
FDA Grants Fast Track Designation for Ambrx’s ARX517 for the Treatment of Metastatic Castration-Resistant Prostate Cancer
TO:
Please use this form to send email to PR contact of this press release:
FDA Grants Fast Track Designation for Ambrx’s ARX517 for the Treatment of Metastatic Castration-Resistant Prostate Cancer
TO: